Sponsors

Point-of-care diabetes testing

Siemens has launched the DCA Vantage analyser, a point-of-care (POC) diabetes patient management platform that provides glycosylated haemoglobin (HbA1c), microalbumin/creatinine and albumin to creatinine tests for diabetes management.

The DCA Vantage analyser is critical for monitoring a patient's glycaemic control and helps clinicians to encourage patient compliance by delivering test results during a patient visit. The system delivers the simplicity and convenience required at the point of care, with no sample or reagent preparation steps.
 The DCA Vantage analyser enables clinicians to provide early detection of kidney disease, the most common complication in patients with diabetes. In addition, there is an onboard glomerular filtration rate (GFR) calculator to assist in kidney disease staging.
 

The DCA Vantage analyser's flexible data management enhancements and testing compliance capabilities help boost productivity by providing speedy access to patient data. The system is network-ready and test results can be shared within the office, clinic or among coordinated POC sites.
www.siemens.com/diagnostics

Latest Issues

Pathology Visions 24

Hyatt Regency, Orlando, FL
3-5 November, 2025

UK NEQAS Cellular Pathology Technique - Annual Participant’s Meeting

America Square Conference Centre, London, EC3N 2LB.
4 - 5 November, 2024

Medica

Messe Dusseldorf
11-14 November, 2024

POCT-for-Scot: Bringing the future to you

SEC Arena, Glasgow
14 November, 2024

Association for Molecular Pathology (AMP) 2024 Annual Meeting & Expo

Hyatt Regency, Vancouver, Canada
19-23 November, 2024